Airway immune responses to COVID-19 vaccination in COPD patients and healthy subjects
COPD patients have a higher risk of developing severe illness and mortality following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection [1]. Vaccination protects against coronavirus disease 2019 (COVID-19) through the development of systemic and airway immune responses. Patients...
Saved in:
Published in | The European respiratory journal Vol. 60; no. 2; p. 2200497 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
European Respiratory Society
01.08.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!